An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Outset Medical, Inc. (Nasdaq: OM) will announce its first quarter 2024 financial results on May 8, 2024. The company will host a conference call to discuss the results, led by Leslie Trigg, Chair, and CEO, and Nabeel Ahmed, CFO.
Outset Medical, Inc. (Nasdaq: OM) annuncerà i risultati finanziari del primo trimestre del 2024 l'8 maggio 2024. La società organizzerà una conferenza telefonica per discutere i risultati, che sarà guidata da Leslie Trigg, presidente e CEO, e Nabeel Ahmed, CFO.
Outset Medical, Inc. (Nasdaq: OM) anunciará sus resultados financieros del primer trimestre de 2024 el 8 de mayo de 2024. La compañía realizará una conferencia telefónica para discutir los resultados, dirigida por Leslie Trigg, presidente y CEO, y Nabeel Ahmed, CFO.
Outset Medical, Inc.(나스닥: OM)는 2024년 5월 8일에 2024년도 1분기 재무 결과를 발표할 예정입니다. 회사는 결과를 논의하기 위해 컨퍼런스 콜을 개최할 것이며, 이는 Leslie Trigg 회장 겸 CEO와 Nabeel Ahmed CFO가 이끌 예정입니다.
Outset Medical, Inc. (Nasdaq : OM) annoncera ses résultats financiers pour le premier trimestre 2024 le 8 mai 2024. L'entreprise organisera une conférence téléphonique pour discuter des résultats, dirigée par Leslie Trigg, président et PDG, et Nabeel Ahmed, directeur financier.
Outset Medical, Inc. (Nasdaq: OM) wird am 8. Mai 2024 seine Finanzergebnisse für das erste Quartal 2024 bekannt geben. Das Unternehmen wird einen Konferenzanruf abhalten, um die Ergebnisse zu besprechen, geleitet von Leslie Trigg, Vorsitzender und CEO, und Nabeel Ahmed, CFO.
Positive
None.
Negative
None.
SAN JOSE, Calif.--(BUSINESS WIRE)--
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.
On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, May 8, 2024. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
When will Outset Medical announce its first quarter 2024 financial results?
Outset Medical will release its financial results on May 8, 2024, after the close of trading.
Who will host the conference call to discuss Outset Medical's financial results?
Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO, will host the conference call.
Where can participants register to listen to the conference call?
Participants can register online to listen to the conference call. Once registered, they will receive dial-in numbers and a unique pin to join the call.
What time will the conference call to discuss Outset Medical's financial results begin?
The conference call will start at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on May 8, 2024.
Will there be a webcast of the event discussing Outset Medical's financial results?
Yes, a live and archived webcast of the event will be available on the 'Investors' section of the Outset website.
Who is the Chair and CEO of Outset Medical?
Leslie Trigg is the Chair and CEO of Outset Medical.
outset is a pioneering medical technology company that always puts the patient before the machine. our human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiencies for providers. and to achieve this goal, we brought together the most dedicated, creative minds from dialysis with the most dedicated, creative minds from other healthcare fields, in the belief that cross-fertilization – along with hard work – is the surest path to invention. because we believe a dialysis machine should be as easy to use as an everyday consumer product, tablo was designed with simplicity in mind. one example is tablo’s touchscreen display, which offers step-by-step pictures and conversational instructions that make it hard to mess up no matter how new a patient, or caregiver, may be to dialysis. and with simplicity comes speed. we’ve set out to give people their time back. tablo dramatically reduces
